Skip to content
Home/Companies/Biotech/Gyroscope Therapeutics
Gyroscope Therapeutics

Gyroscope Therapeutics

Biotech·UK·Exited 2021·Held 2yr
Entry
2019
Hold
2yr
Exit
2021

Who owns Gyroscope Therapeutics?

Gyroscope Therapeutics was owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage) from 2019 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-29

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Websitewww.gyroscopetx.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Seldon
Exited 2026
AI/MLUK· 2020
to
PredictImmune
Exited 2024
HealthTechUK· 2019
Sense Biodetection
Sense Biodetection
Active
MedTechUK· 2019
Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Cytora
Exited 2025
InsurTechUK· 2017
to
Riverlane
Riverlane
Active
Deep TechUK· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Gyroscope Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Gyroscope Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue